Depatuxizumab mafodotin

Ask supplier a question | View on supplier's website

Depatuxizumab Mafodotin (Depatux-M, ABT-414) is an antibody-drug conjugate consisting of an EGFR IGg1 monoclonal antibody conjugated to the tubulin inhibitor monomethyl auristatin F via a stable maleimidocaproyl link. Depatuxizumab Mafodotin is used in the treatment of recurrent EGFR-amplified Glioblastoma (GBM).

Supplier	Selleck Chemicals
Product #	D4042
Sku #	D4042-1mg
Pricing	1mg, $970.00

Feedback